• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

Time Capsule Predictions--Do not open until February 2016





Merck will likely sell off a division(consumer or animal health or both) . Look for a mAjor acquisition in the biologics space, we are too far behind and the internal capabilities just aren't strong enough . We need to be a much bigger player here but lack the internal capabilities. We have a huge potential advantage in our siRNA technology which is the best in the industry by far but we are about to squander that foolishly .

Why wait for 2016 when predictions are realized early?

"huge potential advantage in our siRNA technology"

I don't think so, Dr. R&D...

"Merck & Co., Inc. Cutting Its Losses, While Others Charge Toward RNAi"

http://www.fool.com/investing/gener...nc-cutting-its-losses-while-others-charg.aspx
 








Similar threads

Replies
26
Views
4K
Merck
Anonymous
Replies
20
Views
4K
Merck
Anonymous
Replies
8
Views
3K
Merck
Anonymous
Replies
3
Views
2K
Merck
Anonymous